Nuvation Bio Inc.

This study is testing an oral drug called safusidenib for adults with specific types of brain tumors that have a genetic change called an IDH1 mutation. The main goal is to see if the drug can safely control the tumor and delay its growth or return after standard treatments. The …

This study is testing whether a drug called taletrectinib can prevent early-stage lung cancer from returning after surgery. It will compare the drug to a placebo (sugar pill) in about 180 patients whose cancer has a specific genetic feature called ROS1-fusion. The main goal is to…

This study compares two targeted drugs for advanced lung cancer with a specific genetic change called ROS1. About 138 patients who haven't tried this type of treatment will receive either the experimental drug taletrectinib or the standard drug crizotinib. Researchers want to see…